Hyponatremia Study (Delayed Hyponatremia After Pituitary Surgery)
Key facts
- Who runs it
- Washington University School of Medicine
- Where
- St Louis, United StatesSee the site
- Trial code
- Status
- Completed
- People taking part
- 300 people enrolled
- Started
- 2 Jun 2016
- Ended
- 22 Jul 2024
- Type of study
- Interventional, 2 groupsOne group gets no study treatment, for comparison.
- Treatments tested
- Fluid Restricted Group
- Record updated
- 23 July 2024
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 8 criteriaShow less
Who can take part
- Any adult patient with a pituitary adenoma or cyst (either non-functioning, prolactin-secreting, growth hormone secreting, ACTH (adrenocorticotropic hormone)-secreting, gonadotropin secreting, or TSH secreting) scheduled to undergo pituitary resection
Who cannot take part
- Patients with a history of SIADH (syndrome of inappropriate antidiuretic hormone) , except if secondary to hypothyroidism or adrenal insufficiency, or in association with prior TSS
- Patients with diabetes insipidus or patients receiving DDAVP
- Patients with a history of chronic hyponatremia
- Patients with CKD (chronic kidney disease) stage III, IV or V
- Patients with untreated adrenal insufficiency or hypothyroidism
- Patients with class III or IV heart failure
- Patients without an intact thirst mechanism
Where in United States
- Barnes-Jewish HospitalSt Louis, United States
About the trial
What the trial wants to find out
Hyponatremia is defined as sodium below the normal range of 135-145. Symptomatically, it can cause patients to experience a wide range of symptoms including lethargy, headache, nausea, vomiting and in severe cases coma and even death. The goal of this study is to prospectively compare two approaches to the postoperative fluid management of patients undergoing transsphenoidal resection of a pituitary tumor or cyst to decrease the occurrence of postoperative delayed hyponatremia. One group will be placed on moderate fluid restriction and the other group will be placed on ad lib fluid intake.
The 2 groups in the trial
- Fluid restrictedTreatment being tested
Fluids will be stopped at 8am on POD 1 and patients will be started on a moderate fluid restriction on POD #3 based on their weight (1000 cc/24 hours for patients who weigh \<=100 kg and 1200 cc/24 hours for patients who weigh \> 100kg)
Treatment: Fluid Restricted Group
- Non Fluid RestrictedNo study treatment, for comparison
No fluid restriction
Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Early Fluid Restriction to Prevent Delayed Hyponatremia Following Pituitary Surgery
- Publications
- Record updated
- 23 July 2024